Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie L Goff

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal for Immunotherapy of Cancer|November 30, 2025
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery CommitteeGeorge Coukos, Marco Donia, Brian R Gastman, et al.
The Journal of Clinical Investigation|October 5, 2020
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancerGal Cafri, Jared J Gartner, Tal Zaks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2025
Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous MelanomaPaul H McClelland, Shirley K Nah, Alexandra M Gustafson, et al.
The Lancet. Oncology|April 12, 2017
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 studySmita S Chandran, Robert P T Somerville, James C Yang, et al.
Science (New York, N.Y.)|December 11, 2020
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancerSri Krishna, Frank J Lowery, Amy R Copeland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 LevelsJames N Kochenderfer, Robert P T Somerville, Tangying Lu, et al.
Journal for Immunotherapy of Cancer|May 30, 2024
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypesNoam Levin, Sanghyun P Kim, Charles A Marquardt, et al.
Nature Medicine|July 11, 2024
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim resultsMaria Parkhurst, Stephanie L Goff, Frank J Lowery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic MelanomaShoshana T Levi, Amy R Copeland, Shirley Nah, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 29, 2023
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domainLekha Mikkilineni, Danielle A Natrakul, Norris Lam, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|November 30, 2025
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery CommitteeGeorge Coukos, Marco Donia, Brian R Gastman, et al.
The Journal of Clinical Investigation|October 5, 2020
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancerGal Cafri, Jared J Gartner, Tal Zaks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2025
Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous MelanomaPaul H McClelland, Shirley K Nah, Alexandra M Gustafson, et al.
The Lancet. Oncology|April 12, 2017
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 studySmita S Chandran, Robert P T Somerville, James C Yang, et al.
Science (New York, N.Y.)|December 11, 2020
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancerSri Krishna, Frank J Lowery, Amy R Copeland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 LevelsJames N Kochenderfer, Robert P T Somerville, Tangying Lu, et al.
Journal for Immunotherapy of Cancer|May 30, 2024
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypesNoam Levin, Sanghyun P Kim, Charles A Marquardt, et al.
Nature Medicine|July 11, 2024
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim resultsMaria Parkhurst, Stephanie L Goff, Frank J Lowery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic MelanomaShoshana T Levi, Amy R Copeland, Shirley Nah, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 29, 2023
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domainLekha Mikkilineni, Danielle A Natrakul, Norris Lam, et al.
Pageof 6